AKT1 and breast cancer: Tamoxifen (TAM), a commonly used drug BC, promotes HMGB3 expression and secretion in CAFs through GPR1 / PI30K/AKT signaling, and secretion of HMGB1 (Figure 3) induces autophagy to enhance TAM resistance in MCF-7 cells 35.